These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 3135799)

  • 21. Structural study of phenyl boronic acid derivatives as AmpC beta-lactamase inhibitors.
    Tondi D; Calò S; Shoichet BK; Costi MP
    Bioorg Med Chem Lett; 2010 Jun; 20(11):3416-9. PubMed ID: 20452208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pH-dependence of class B and class C beta-lactamases.
    Bicknell R; Knott-Hunziker V; Waley SG
    Biochem J; 1983 Jul; 213(1):61-6. PubMed ID: 6604522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-turnover and steady-state kinetics of hydrolysis of cephalosporins by beta-lactamase I from Bacillus cereus.
    Bicknell R; Waley SG
    Biochem J; 1985 Oct; 231(1):83-8. PubMed ID: 3933490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase.
    Bouza AA; Swanson HC; Smolen KA; VanDine AL; Taracila MA; Romagnoli C; Caselli E; Prati F; Bonomo RA; Powers RA; Wallar BJ
    ACS Infect Dis; 2018 Mar; 4(3):325-336. PubMed ID: 29144724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Boronic Acid Transition State Inhibitors Active against KPC and Other Class A β-Lactamases: Structure-Activity Relationships as a Guide to Inhibitor Design.
    Rojas LJ; Taracila MA; Papp-Wallace KM; Bethel CR; Caselli E; Romagnoli C; Winkler ML; Spellberg B; Prati F; Bonomo RA
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1751-9. PubMed ID: 26729496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thermodynamic evaluation of a covalently bonded transition state analogue inhibitor: inhibition of beta-lactamases by phosphonates.
    Nagarajan R; Pratt RF
    Biochemistry; 2004 Aug; 43(30):9664-73. PubMed ID: 15274621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases.
    Chen Y; Shoichet B; Bonnet R
    J Am Chem Soc; 2005 Apr; 127(15):5423-34. PubMed ID: 15826180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase.
    Buzzoni V; Blazquez J; Ferrari S; Calò S; Venturelli A; Costi MP
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3979-83. PubMed ID: 15225711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of Bacillus cereus 569/H beta-lactamase I by 6-beta-(trifluoromethane sulfonyl)amidopenicillanic acid sulfone and its N-methyl derivative.
    Clarke AJ; Mezes PS; Vice SF; Dmitrienko GI; Viswanatha T
    Biochim Biophys Acta; 1983 Nov; 748(3):389-97. PubMed ID: 6315063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cryoenzymology of Bacillus cereus beta-lactamase II.
    Bicknell R; Waley SG
    Biochemistry; 1985 Nov; 24(24):6876-87. PubMed ID: 3935166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unexpected tricovalent binding mode of boronic acids within the active site of a penicillin-binding protein.
    Zervosen A; Herman R; Kerff F; Herman A; Bouillez A; Prati F; Pratt RF; Frère JM; Joris B; Luxen A; Charlier P; Sauvage E
    J Am Chem Soc; 2011 Jul; 133(28):10839-48. PubMed ID: 21574608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-lactamases as fully efficient enzymes. Determination of all the rate constants in the acyl-enzyme mechanism.
    Christensen H; Martin MT; Waley SG
    Biochem J; 1990 Mar; 266(3):853-61. PubMed ID: 2158301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting class A and C serine β-lactamases with a broad-spectrum boronic acid derivative.
    Tondi D; Venturelli A; Bonnet R; Pozzi C; Shoichet BK; Costi MP
    J Med Chem; 2014 Jun; 57(12):5449-58. PubMed ID: 24882105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of metallo-beta-lactamases by a series of mercaptoacetic acid thiol ester derivatives.
    Payne DJ; Bateson JH; Gasson BC; Proctor D; Khushi T; Farmer TH; Tolson DA; Bell D; Skett PW; Marshall AC; Reid R; Ghosez L; Combret Y; Marchand-Brynaert J
    Antimicrob Agents Chemother; 1997 Jan; 41(1):135-40. PubMed ID: 8980769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectrophotometric determination of inhibitory effects of CP-45899 on beta-lactamase with benzylpenicillin and nitrocefin.
    Yamabe S
    J Antimicrob Chemother; 1980 May; 6(3):420-1. PubMed ID: 6249784
    [No Abstract]   [Full Text] [Related]  

  • 36. Structure-based design of a potent transition state analogue for TEM-1 beta-lactamase.
    Strynadka NC; Martin R; Jensen SE; Gold M; Jones JB
    Nat Struct Biol; 1996 Aug; 3(8):688-95. PubMed ID: 8756327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The variation of catalytic efficiency of Bacillus cereus metallo-beta-lactamase with different active site metal ions.
    Badarau A; Page MI
    Biochemistry; 2006 Sep; 45(35):10654-66. PubMed ID: 16939217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzyme deactivation due to metal-ion dissociation during turnover of the cobalt-beta-lactamase catalyzed hydrolysis of beta-lactams.
    Badarau A; Page MI
    Biochemistry; 2006 Sep; 45(36):11012-20. PubMed ID: 16953588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitrogen-15 NMR spectroscopy of the catalytic-triad histidine of a serine protease in peptide boronic acid inhibitor complexes.
    Bachovchin WW; Wong WY; Farr-Jones S; Shenvi AB; Kettner CA
    Biochemistry; 1988 Oct; 27(20):7689-97. PubMed ID: 3207700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetic and inhibition studies of Bacillus cereus beta-lactamase using a spectrophotometric method.
    Münch R; Wombacher H; Körber F
    J Clin Chem Clin Biochem; 1981 Sep; 19(9):953-60. PubMed ID: 6793687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.